ReportWire

Tag: health policy

  • MBTA balks at expanding overdose prevention kiosks

    [ad_1]

    BOSTON — MBTA officials are pouring cold water on a legislative push to make the opioid overdose reversing drug naloxone available at subway stations, citing a lack of proper staff and a shortage of funding.

    The T recently wrapped up a federally funded pilot project that installed 15 kiosks with doses of the medicine – also known by its brand name, Narcan – at several Red Line stations to help reduce fatal drug overdoses.


    This page requires Javascript.

    Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

    kAmqFE 😕 2 ?6H C6A@CE E@ E96 {68:D=2EFC6[ E96 42D9DEC2AA65 AF3=:4 EC2?D:E 286?4J D2:5 :E 92D “56E6C>:?65 E92E :E 5@6D ?@E 4FCC6?E=J 92G6 DF77:4:6?E C6D@FC46D @C 2AAC@AC:2E6 A6CD@??6= ?66565 E@ >2?286 E96 52JE@52J 25>:?:DEC2E:@? @7 DF49 2 AC@8C2>]”k^Am

    kAm“%96 |q%p C64@8?:K6D 2?5 DFAA@CED E96 :>A@CE2?46 @7 AC@>@E:?8 92C> C65F4E:@? 677@CED 2?5 :?4C62D:?8 AF3=:4 2446DD E@ =:76D2G:?8 >65:42E:@? E92E 42? C6G6CD6 2? @A:@:5 @G6C5@D6[” {J?D6J w6776C?2?[ E96 %’D 49:67 @7 A@=:4J U2>Aj DEC2E68:4 A=2??:?8[ HC@E6 😕 E96 C6A@CE] “x? E96 6G6?E DE277:?8 2?5 AC@8C2> >2?286>6?E 42? 36 >256 2G2:=23=6 7C@> 2 E9:C5 A2CEJ[ E96 |q%p 42? 4@?E:?F6 E@ >2<6 DA246 2G2:=23=6 😕 :ED 724:=:E:6D E@ DFAA@CE E96 AC@8C2>]”k^Am

    kAm(9:=6 |q%p %C2?D:E !@=:46 92G6 2?5 H:== 4@?E:?F6 E@ 42CCJ ?2=@I@?6[ E96 % C64@>>6?565 E92E 2?J 7FEFC6 AF3=:4 2446DD AC@8C2> 😕 @C ?62C DE2E:@?D 36 “>2?2865 3J 2 E9:C5 A2CEJ” H9@D6 >:DD:@? “:D 2=:8?65 H:E9 DF49 2? :>A@CE2?E AC@8C2> 2?5 E92E 92D E96 C6D@FC46D 2?5 A6CD@??6= E@ >@?:E@C 2?5 C6DFAA=J ?2=@I@?6 2D H6== 2D E@ >2?286 7@C E6>A6C2EFC6 7=F4EF2E:@?D]”k^Am

    kAm%96 C6A@CE 4@>6D 2D q624@? w:== =2H>2<6CD AFD9 A2DD286 @7 =68:D=2E:@? E92E 42==D 7@C >2<:?8 E96 A:=@E AC@8C2> A6C>2?6?E 24C@DD E96 %’D DF3H2J DJDE6>] %96 =68:D=2E:@?[ :7 2AAC@G65[ H@F=5 C6BF:C6 |q%p DE2E:@?D E@ 92G6 2E =62DE EH@ “7C66DE2?5:?8 F?2=2C>65 ?2=@I@?6 3@I6D” 6249 4@?E2:?:?8 EH@ F?:ED @7 E96 @G6C5@D6C6G6CD:?8 DAC2J 2G2:=23=6 7@C AF3=:4 FD6]k^Am

    kAm“uC2?<=J[ x 36=:6G6 6G6CJ 3FD 2?5 4@>>FE6C C2:= 42C D9@F=5 92G6 ?2=@I@?6[” DE2E6 $6?] y@9? z6??2?[ 2 “F:?4J s6>@4C2E 2?5 E96 3:==’D AC:>2CJ DA@?D@C[ D2:5 😕 E6DE:>@?J 367@C6 E96 {68:D=2EFC6’D r@>>:EE66 @? %C2?DA@CE2E:@? 62C=:6C E9:D >@?E9] “xE D9@F=5 36 2D 4@>>@? 2D 7:C6 6IE:?8F:D96CD 2?5 =:89E 3F=3D]”k^Am

    [ad_2]

    By Christian M. Wade | Statehouse Reporter

    Source link

  • Rockport school board updated on opioid prevention

    [ad_1]

    The Rockport School Committee, along with the town’s Public Health Department, is aiming to eliminate the effects of possible substance abuse in Rockport schools.

    During the committee’s meeting on June 4, members heard from Dr. Ray Cahill, director of the Rockport Public Health Department, who updated those gathered about the “RIZE Mosaic Opioid Recovery Partnership Grant.” The grant aims to support children and families affected by the opioid crisis.


    This page requires Javascript.

    Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

    kAm%96 8C2?E AC@8C2> 😀 2 ?6H :?:E:2E:G6 7@4FD65 @? 96=A:?8 E9@D6 724:?8 @A:@:5 255:E:@? AC@3=6>D[ r29:== D2:5]k^Am

    kAm“|F?:4:A2=:E:6D 24C@DD E96 4@>>@?H62=E9 92G6 366? 23=6 E@ 2AA=J 7@C @?6J62C >2E49:?8 8C2?ED[” 96 D2:5[ 255:?8 E92E A2CE @7 E96 :?:E:2E:G6 DEC:G6D E@ C65F46 E96 DE:8>2D 2DD@4:2E65 H:E9 @A:@:5 23FD6 2?5 7@DE6C 2 >@C6 DFAA@CE:G6 2?5 :?7@C>65 6?G:C@?>6?E C6=2E65 E@ “@A:@:5 FD6 5:D@C56C]”k^Am

    kAm“%96 E9C66 4@>>F?:E:6D A@@=65 S`d_[___ 2?5 E92E H2D >2E4965[” 96 D2:5] “$@[ E96 E@E2= 8C2?E 😀 Sb__[___]”k^Am

    kAm%96 8C2?E 😀 >2?2865 3J E96 #x+t |2DD249FD6EED u@F?52E:@?[ 2 q@DE@? ?@?AC@7:E 565:42E65 E@ 7F?5:?8 2?5 4C62E:?8 D@=FE:@?D E@ 6?5 E96 @G6C5@D6 4C:D:D 😕 |2DD249FD6EED]k^Am

    kAm“%96 @G6C2C49:?8 8@2= @7 E9:D :?:E:2E:G6 😀 H6 2C6 H@C<:?8 E@ 56G6=@A 2? 64@DJDE6> H96C6 H6 42? C65F46 32CC:6CD E92E :?5:G:5F2=D 7246 H96? E96J’C6 D66<:?8 EC62E>6?E 2?5 C64@G6CJ D6CG:46D[” r29:== D2:5]k^Am

    kAmp 4@>>F?:EJ DFCG6J H2D C646?E=J 4@?5F4E65 @? r2A6 p??[ 96 D2:5[ H9:49 :?5:42E65 E96 7@==@H:?8 E@A 32CC:6CD E@ DF3DE2?46 23FD6 C64@G6CJ AC@8C2>Dik^Am

    kAm %96 4@DE @7 D@36C =:G:?8 AC@8C2>Dk^Am

    kAm %96 4@DE @7 AC6D4C:AE:@? 5CF8D FD65 😕 EC62E>6?Ek^Am

    kAm p446DD 2?5 4@DE C6=2E65 E@ EC2?DA@CE2E:@? E@ >65:42= 2AA@:?E>6?ED 2?5 >65:42= 724:=:E:6Dk^Am

    kAm $E:8>2D C6=2E65 E@ @A:@:5 FD6 5:D@C56Ck^Am

    kAm“xE H2D G6CJ 4=62C H92E E96 E@A 92?57F= @7 32CC:6CD H6C6[” r29:== D2:5]k^Am

    kAm!2CE @7 E96 677@CE ?@H H:== :?4=F56 2 4@>>F?:EJ @FEC6249 AC@46DD E@ D92C6 :?7@C>2E:@? 23@FE E96 8C2?E AC@8C2> E9C@F89@FE E96 4@>>F?:EJ[ 96 D2:5]k^Am

    kAmr29:== 5:5 A@:?E @FE E92E E96 :?:E:2E:G6 😀 ?@E D66? 2D 2 A2?2462 7@C 2== AC@3=6>D C6=2E65 E@ DF3DE2?46 23FD6]k^Am

    kAm“%96C6’D ?@E 2 @?6D:K67:ED2== D@=FE:@? H96? :E 4@>6D E@ 255:4E:@?[” 96 D2:5] “%96C6’D 2 3C@25 DA64ECF> @7 ?665D] x7 H6’C6 8@:?8 E@ 92G6 2 D:8?:7:42?E :>A24E[ H6 ?665 E@ 36 E2=<:?8 23@FE E9:D 2?5 H6 ?665 E@ 36 A@@=:?8 @FC C6D@FC46D 2?5 A@@=:?8 @FC E9@F89ED]k^Am

    kAm“xE’D C62==J E96 @?=J A2E9 E@ 4@>:?8 FA H:E9 4@?DECF4E:G6 @AA@CEF?:E:6D 7@C :?E6CG6?E:@?] z66A:?8 J@FE9 D276 😀 A2C2>@F?E]”k^Am

    kAmk6>m$E6A96? w282? 42? 36 C624965 2E hfgefdaf_g @C 2E k2 9C67lQ>2:=E@iD9282?o8=@F46DE6CE:>6D]4@>QmD9282?o8=@F46DE6CE:>6D]4@>k^2m]k^6>mk^Am

    [ad_2]

    By Stephen Hagan | Staff Writer

    Source link

  • Data: Fewer opioids prescribed in Mass., NH

    Data: Fewer opioids prescribed in Mass., NH

    [ad_1]

    BOSTON — While the scourge of opioid addiction continues to affect Massachusetts, the number of people getting legal prescriptions for heavily addictive medicines is falling, according to the latest federal data.

    Massachusetts had the second lowest opioid prescription rate in New England in 2022, following Vermont, the U.S. Centers for Disease Control and Prevention reported. Health care providers in the Bay State wrote 30.8 opioid prescriptions for every 100 residents, the federal agency reported.

    That’s a slight drop from the previous year but a substantial decline from the 66 per 100 prescription rate in 2006, when the CDC began tracking the data, which lags by two years.

    New Hampshire, which has also seen declining numbers of opioid prescriptions in recent years, had the third-lowest rate in New England in 2022, with 32 prescriptions for every 100 residents. Maine had the highest rate in the region, or 35.2 per 100 residents.

    Nationally, the overall prescription rate was 39.5 prescriptions per 100 people in 2022, according to the CDC data.

    Curbing opioid addiction has been a major focus on Beacon Hill for a number of years, with hundreds of millions of dollars being devoted to expanding treatment and prevention efforts.

    For many, opioid addiction has its roots in prescription painkillers such as Oxycontin and Percocet, which led them to street-bought heroin and fentanyl once those prescriptions ran out.

    In 2016, then-Gov. Charlie Baker and lawmakers pushed through a raft of rules to curb over-prescribing of opioids. Those included a cap on new prescriptions written in any seven-day period and a requirement that doctors consult a state prescription monitoring database before prescribing an additive opioid.

    Meanwhile opioid manufacturers have been hammered with hundreds of lawsuits from the states and local governments over their role in fueling a wave of opioid addiction. Attorney General Maura Healey’s office recently agreed to a multi-billion dollar settlement with OxyContin maker Purdue Pharma.

    Supporters of the tougher requirements say they have saved lives by dramatically reducing the number of heavily addictive opioids being prescribed.

    Pain management groups say the regulatory backlash has made some doctors worried about writing prescriptions for opioids, depriving patients of treatment.

    There were 2,125 confirmed or suspected opioid-related deaths in 2023 — which is 10%, or 232, fewer fatal overdoses than the same period in 2022, according to the latest data from the state Department of Public Health.

    Last year’s opioid-related overdose death rate also decreased by 10% to 30.2 per 100,000 people compared with 33.5 in 2022, DPH said.

    Health officials attributed the persistently high death rates to the effects of an “increasingly poisoned drug supply,” primarily with the powerful synthetic opioid fentanyl. Fentanyl was present in 90% of the overdose deaths where a toxicology report was available, state officials noted.

    Nationally, there were 107,543 overdose deaths reported in the U.S. in 2023, a 3% decrease from the estimated 111,029 in 2022, according to CDC data.

    On Beacon Hill, state lawmakers are being pressured to take more aggressive steps to expand treatment and prevention options for those struggling with opioid addiction.

    Last month, a coalition of more than 100 public health and community-based organizations wrote to House and Senate leaders urging them to pass substance abuse legislation before the Dec. 31 end of the two-year session.

    “There isn’t a day that goes by without several people in the Commonwealth dying from an overdose or losing loved ones to this disease,” they wrote. “As individuals and institutions working to combat the opioid epidemic, we know the Commonwealth must do more to prevent addiction, help people find pathways to treatment and recovery, and save lives.”

    Christian M. Wade covers the Massachusetts Statehouse for North of Boston Media Group’s newspapers and websites. Email him at cwade@cnhinews.com.

    [ad_2]

    By Christian M. Wade | Statehouse Reporter

    Source link

  • Data: Fewer opioids prescribed in Massachusetts

    Data: Fewer opioids prescribed in Massachusetts

    [ad_1]

    BOSTON — While the scourge of opioid addiction continues to affect Massachusetts, the number of people getting legal prescriptions for heavily addictive medicines is falling, according to the latest federal data.

    Massachusetts had the second lowest opioid prescription rate in New England in 2022, following Vermont, the U.S. Centers for Disease Control and Prevention reported. Health care providers in the Bay State wrote 30.8 opioid prescriptions for every 100 residents, the federal agency reported.

    That’s a slight drop from the previous year but a substantial decline from the 66 per 100 prescription rate in 2006, when the CDC began tracking the data, which lags by two years.

    New Hampshire, which has also seen declining numbers of opioid prescriptions in recent years, had the third-lowest rate in New England in 2022, with 32 prescriptions for every 100 residents. Maine had the highest rate in the region, or 35.2 per 100 residents.

    Nationally, the overall prescription rate was 39.5 prescriptions per 100 people in 2022, according to the CDC data.

    Curbing opioid addiction has been a major focus on Beacon Hill for a number of years, with hundreds of millions of dollars being devoted to expanding treatment and prevention efforts.

    For many, opioid addiction has its roots in prescription painkillers such as Oxycontin and Percocet, which led them to street-bought heroin and fentanyl once those prescriptions ran out.

    In 2016, then-Gov. Charlie Baker and lawmakers pushed through a raft of rules to curb over-prescribing of opioids. Those included a cap on new prescriptions written in any seven-day period and a requirement that doctors consult a state prescription monitoring database before prescribing an additive opioid.

    Meanwhile opioid manufacturers have been hammered with hundreds of lawsuits from the states and local governments over their role in fueling a wave of opioid addiction. Attorney General Maura Healey’s office recently agreed to a multi-billion dollar settlement with OxyContin maker Purdue Pharma.

    Supporters of the tougher requirements say they have saved lives by dramatically reducing the number of heavily addictive opioids being prescribed.

    Pain management groups say the regulatory backlash has made some doctors worried about writing prescriptions for opioids, depriving patients of treatment.

    There were 2,125 confirmed or suspected opioid-related deaths in 2023 — which is 10%, or 232, fewer fatal overdoses than the same period in 2022, according to the latest data from the state Department of Public Health.

    Last year’s opioid-related overdose death rate also decreased by 10% to 30.2 per 100,000 people compared with 33.5 in 2022, DPH said.

    Health officials attributed the persistently high death rates to the effects of an “increasingly poisoned drug supply,” primarily with the powerful synthetic opioid fentanyl. Fentanyl was present in 90% of the overdose deaths where a toxicology report was available, state officials noted.

    Nationally, there were 107,543 overdose deaths reported in the U.S. in 2023, a 3% decrease from the estimated 111,029 in 2022, according to CDC data.

    On Beacon Hill, state lawmakers are being pressured to take more aggressive steps to expand treatment and prevention options for those struggling with opioid addiction.

    Last month, a coalition of more than 100 public health and community-based organizations wrote to House and Senate leaders urging them to pass substance abuse legislation before the Dec. 31 end of the two-year session.

    ”There isn’t a day that goes by without several people in the Commonwealth dying from an overdose or losing loved ones to this disease,” they wrote. “As individuals and institutions working to combat the opioid epidemic, we know the Commonwealth must do more to prevent addiction, help people find pathways to treatment and recovery, and save lives.”

    Christian M. Wade covers the Massachusetts Statehouse for North of Boston Media Group’s newspapers and websites. Email him at cwade@cnhinews.com.

    [ad_2]

    By Christian M. Wade | Statehouse Reporter

    Source link

  • Anna Jaques Hospital awards $100K in grants

    Anna Jaques Hospital awards $100K in grants

    [ad_1]

    NEWBURYPORT — Anna Jaques Hospital will award $100,000 in grant money over the next two years to 10 community-based organizations serving the health needs of area residents.

    The grants are part of the hospital’s Community Benefits Program to support programs that address community health priorities and help those facing the greatest health inequities within the hospital’s service area, according to a release from Anna Jaques.

    Residents of Newburyport, Amesbury, Haverhill, Salisbury and Merrimac will benefit from the funding. Anna Jaques is part of Beth Israel Lahey Health.

    The selection criteria for the grants included four major health priorities affecting the community that were identified during the hospital’s most recent Community Health Needs Assessment, completed in 2022: equitable access to care, social determinants of health, mental health and substance use, and chronic/complex conditions.

    “By supporting and investing in local organizations that share our goal in addressing the health needs of our region, we improve the quality of life for local residents while strengthening the communities that we serve,” Glenn Focht, M.D., the hospital’s president, said in the release.

    “We are proud to support these local organizations and the important work they do to reduce health disparities and inequities throughout our region,” he added.

    The following 10 nonprofit organizations will receive two-year grants of $5,000 per year, for a total of $10,000:

    Common Ground Ministries: This program provides basic services aimed at alleviating hunger and homelessness while being an advocate for those in need. The grant will help 90 to 100 people who the program serves each day.

    Mitch’s Place, Emmaus, Inc.: This temporary overnight emergency shelter provides adults with a bed, meals, and housing search and employment assistance along with help securing permanent housing and health and social services. The money will help the shelter serve the 400 people it assists annually.

    McKinney-Vento Program, Haverhill Public Schools: The grant will fund food programs, including food closets and a food pantry program, for families whose children attend Haverhill Public Schools and are experiencing homelessness. The program seeks to help an additional 40 students and up to 15% more families.

    Jeanne Geiger Crisis Center, Youth Empowerment Series: This series provides violence prevention programs that teach students of all ages to lead conversations on healthy relationships and to make positive decisions. The money will fund expansion of the series into Newburyport, allowing the program to serve an additional 100 to 150 participants.

    Link House: Children and Teen Center for Help (CATCH): CATCH seeks to empower and support those ages 5 to 18 and their families across the region to understand and nurture their mental well-being. The funding will help to increase the number of young people served by 10%.

    Northern Essex Elder Transport (NEET): This volunteer driver program provides adults age 60 and older across the region with no-cost transportation to medical appointments. The funding will support the 4,000 rides provided to 500 people annually.

    Nourishing the Northshore: VEGOUT program: This program provides free fresh, locally grown produce to food pantries and senior centers across the region from June to October. The money will help provide 280,000 servings of food — a 55% increase from 2023.

    Our Neighbors’ Table: Wednesday Meal Program: The grant will assist this weekly community program based in Amesbury, which provides a hot, three-course meal served by volunteers or as carry-out orders to 300 people each Wednesday.

    The Pettengill House: Behavioral Event and Substance Support Team (BESST): The money will provide a social worker and support for people and families with mental health and substance abuse needs in Merrimac, Salisbury, Amesbury and Newburyport. The program assisted 462 people in 321 households in 2023.

    Sarah’s Place Adult Health Center: This senior adult day health program offers outreach and education to assist people in remaining healthy and independent in their own homes. The funding will help enroll an additional 25 to 50 participants in the program.

    [ad_2]

    Source link

  • Opioid deaths drop 10%, but remain high

    Opioid deaths drop 10%, but remain high

    [ad_1]

    BOSTON — The scourge of opioid addiction continues to affect Massachusetts, but new data shows a double-digit decrease in the number of overdose deaths in the past year.

    There were 2,125 confirmed or suspected opioid-related deaths in 2023 — which is 10%, or 232, fewer fatal overdoses than during the same period in 2022, according to a report released this week by the state Department of Public Health.

    Last year’s opioid-related overdose death rate also decreased by 10% to 30.2 per 100,000 people compared to 33.5 in 2022, DPH said.

    Health officials attributed the persistently high death rates to the effects of an “increasingly poisoned drug supply,” primarily with the powerful synthetic opioid fentanyl.

    Fentanyl was present in 90% of the overdose deaths where a toxicology report was available, state officials noted.

    Preliminary data from the first three months of 2024 showed a continued decline in opioid-related overdose deaths, the agency said, with 507 confirmed and estimated deaths, a 9% drop from the same time period last year.

    Gov. Maura Healey said she is “encouraged” by the drop in fatal overdoses but the state needs to continue to focus on “prevention, treatment and recovery efforts to address the overdose crisis that continues to claim too many lives and devastate too many families in Massachusetts.”

    Substance abuse counselors welcomed the declining number of fatal opioid overdoses, but said the data shows that there is still more work to be done to help people struggling with substance use disorders.

    “While the number of opioid-related overdose deaths in the commonwealth remains unacceptably high, it is encouraging to see what we hope is a reversal of a long and painful trend,” Bridgewell President & CEO Chris Tuttle said in a statement. “The time is now to boost public investments and once and for all overcome the scourge of the opioid epidemic.”

    Nationally, there were 107,543 overdose deaths reported in the U.S. in 2023, a 3% decrease from the estimated 111,029 in 2022, according to recently released U.S. Centers for Disease Control and Prevention data.

    In New Hampshire, drug overdose deaths also declined by double digits in 2023, according to figures released in May by the state’s medical examiner and the National Centers for Disease Control.

    There were 430 deaths attributed to overdoses in 2023, an 11.7% decrease from 2022’s 487, according to the data.

    Curbing opioid addiction has been a major focus on Beacon Hill for a number of years with hundreds of millions of dollars being devoted to expanding treatment and prevention efforts.

    The state has set some of the strictest opioid-prescribing laws in the nation, including a cap on new prescriptions in a seven-day period and a requirement that doctors consult a state prescription monitoring database before prescribing an addictive opioid.

    Hundreds of millions of dollars are flowing into the state from multistate settlements with opioid makers and distributors, including $110 million from a $6 billion deal with OxyContin maker Purdue Pharma and the Sackler family.

    Under state law, about 60% of that money will be deposited in the state’s opioid recovery fund, while the remainder will be distributed to communities.

    Earlier this week, House lawmakers were expected to take up a package of bills aimed at improving treatment of substance abuse disorders and reducing opioid overdose deaths.

    The plan would require private insurers to cover emergency opioid overdose-reversing drugs such as naloxone and require drug treatment facilities to provide two doses of overdose-reversal drugs when discharging patients, among other changes.

    Another provision would require licenses for recovery coaches, who are increasingly sent to emergency rooms, drug treatment centers and courtrooms to help addicts get clean.

    Backers of the plan said the goal is to integrate peer recovery coaches more into the state’s health care system, helping addicts who have taken the first steps toward recovery.

    Long-term recovery remains one of the biggest hurdles to breaking the cycle of addiction, they say.

    Christian M. Wade covers the Massachusetts Statehouse for North of Boston Media Group’s newspapers and websites. Email him at cwade@cnhinews.com.

    [ad_2]

    By Christian M. Wade | Statehouse Reporter

    Source link

  • Few prepared to cover long-term care costs

    Few prepared to cover long-term care costs

    [ad_1]

    Editor’s note: The share of the U.S. population older than 65 keeps rising – and will for decades to come. Since nearly half of Americans over 65 will pay for some version of long-term health care, CNHI News and The Associated Press examined the state of long-term care in the series High Cost of Long-Term Care, which began Friday and continues this week.

    While many Americans will need long-term care as they get older, few are prepared to pay for it.

    Medicare, which provides Americans over the age 65 with health insurance, doesn’t cover most long-term care services. And Medicaid — the primary safety net for long-term care coverage — only covers those who are indigent.

    Federal estimates suggest 70% of people ages 65 and older will need long-term care before they die, but only 3% to 4% of Americans age 50 and older are paying for long-term care policies, according to insurance industry figures.

    The high cost of premiums for those private long-term care policies puts it out of reach for most people.

    Even some who have this kind of insurance find it doesn’t provide enough to cover the costs of home health aides, assisted-living facilities or nursing homes.

    “People think that long-term care insurance is for everyone — but it is not,” said Jessie Slone, executive director of the American Association for Long-term Care Insurance, an advocacy group. “It’s for a very small subset of individuals who plan, and have some retirement assets and income they can use to pay for it.”

    To qualify, applicants need to pass a health review. Slone said insurance companies have underwriting policies with “page after page” of conditions that will disqualify people from getting that coverage.”If you live a long life, the chances of you needing care are significant. So then the issue becomes who’s going to provide for that care, and who’s going to pay for it. For some, long-term care insurance is an option.”

    Prices vary, based on the age when people apply, how good their health is at the time, and how much coverage they want. “You have to start looking at this generally in your 50s or 60s,” Slone said. “Because, as you get older, you’re going to have conditions which insurers are going to look at, determine that you’re very likely to need long-term care and not give you a policy.”

    That coverage, if you can get it, doesn’t come cheap: In 2023, the annual average cost for a policy for a couple both age 55, taking out a $165,000 initial pool growing at 3% compounded annually — ranged from a low of $5,018 to $14,695 a year, according to the association.

    But, compared to auto insurance — which most people may never use — long-term care insurance is a good investment for those who can afford it, Slone said. “Car insurance is the most expensive insurance you ever pay because the chances of you getting into a car accident are somewhat remote. But the chances of someone needing long-term care if they make it to 90 are pretty significant.”

    Lori Smetanka, executive director of the National Consumer Voice for Quality Long-Term Care, a national nonprofit advocacy group, views it differently. She said the private long-term care insurance system has become a “bust” amid rising premiums and difficulties accessing benefits.

    Consider the fact that the number of companies offering long-term care insurance is declining, while payouts are steadily increasing as the baby boomer generation ages.”Most people have found it very expensive,” Smetanka said. “But, at the same time, people are finding that it wasn’t covering what they needed.”

    Last year, insurers paid a record of more than $14 billion to cover an estimated 353,000 long-term care claims, according to industry figures. That’s compared to about $11.6 billion just three years ago.

    Currently, there are about 7.5 million people in the U.S. age 65 and older with private long-term care insurance, according to industry data.

    With that incentive, some states, including Washington and California, are looking at creating long-term care social insurance pools funded by payroll taxes and other sources of funding. The effort also is being spurred, in part, by the rising costs borne by states for Medicaid long-term care coverage, which they share with the federal government.

    “More and more states are coming to the conclusion that this is an under-funded system,” said Marc Cohen, a researcher and co-director of the LeadingAge LTSS Center at the University of Massachusetts at Boston. “There are simply not enough dollars going into the system – given the needs and the demands of the growing elderly population.”

    So far, Washington is the only state to try to address the issue. A law approved by the state Legislature in 2019 created a long-term care benefit program, which provides residents with up to $36,500 to pay for costs such as caregiving, wheelchair ramps, meal deliveries and nursing home fees.

    The Cares Funds is covered by a payroll tax that deducts 0.58% out of paychecks but guarantees a $36,500 lifetime benefit for those who have paid into the fund for 10 years.

    Several other states are studying the issue. In California, a task force is looking at how to design a long-term care program, according to the National Conference of State Legislatures. Massachusetts, Illinois and Michigan also are weighing the costs versus benefits of creating a state long-term care benefits program.

    But the issue of imposing new taxes to pay for long-term care insurance is controversial — and politically unpopular — on both a state and federal level.

    Washington’s long-term care insurance law is facing a repeal effort from a group backed by hedge fund executive Brian Heywood that argues the system should be voluntary. Voters in November will decide whether to allow people to opt out, which supporters say would essentially gut the program.

    “There are a lot of states that are looking to see what happens in Washington,” Cohen said. “If this billionaire who is funding this repeal effort wins, it will be a real blow.”

    Cohen said efforts on a federal level to create a publicly funded insurance pool haven’t gained much traction. A long-term care program created by Congress through the CLASS Plan, which was tied to the Affordable Care Act, was voluntary. That law was repealed in early 2013.

    “It never got off the ground before it was repealed,” he said. “With the dysfunction in Congress, we’re likely to see more action on a state level than the federal.”

    Recent polls suggest there may be some public support for the move. A survey by the National Council on Aging found more than 90% of the 1,000 female respondents across party lines support the idea of creating a government program to pay for the cost of long-term care.

    “The level of support was significant, and very bipartisan,” said Howard Bedlin, a long-term care expert with the council. “People keep talking about how Congress can’t find bipartisan support. Well, the voters clearly support it.

    “The politicians just aren’t giving these issues the attention they deserve.”

    Christian M. Wade is a reporter for North of Boston Media Group.

    [ad_2]

    By Christian M. Wade | CNHI News

    Source link

  • Report: Injured workers at risk for opioid overdoses

    Report: Injured workers at risk for opioid overdoses

    [ad_1]

    Workers who are injured on the job are at higher risk for fatal opioid-related overdoses, according to a new study, which calls for renewed efforts to reduce the stigma of drug addiction.

    The report, released Thursday by the state Department of Public Health, found that working-age Massachusetts residents who died between 2011 and 2020 were 35% more likely to have died of an opioid-related overdose if they had previously been injured at work.

    DPH researchers compiled information about individuals’ employment and work-related injury status from their workers’ compensation claims and linked it with data from their death certificates.

    Researchers reviewed the details of 4,304 working-age adults who died between 2011 and 2020 and found at least 17.2% had at least one workplace injury claim and died of an opioid-related overdose, according to the study.

    Public health officials say the study is the first linking the impact of work-related injuries to opioid-related overdose deaths.

    “Occupational injuries can take both a physical and mental toll, and those who suffer injuries at work may be discouraged from seeking help because of stigmatization and fear of losing their jobs,” Health and Human Services Secretary Kate Walsh said in a prepared statement. “Avoiding or delaying care can lead to a preventable overdose death.”

    She called for stepped-up efforts to “eliminate the stigma that accompanies substance use disorder in all sectors of society, including the workplace.”

    The release of the report comes as opioid overdose deaths remain devastatingly high in the Bay State, despite a slight decrease over the past year.

    There were 2,323 confirmed or suspected opioid-related deaths in Massachusetts from Oct. 1, 2022 to Sept. 30, 2023 — eight fewer than the same period in 2021, according to a report released in December by the health department.

    Health officials attributed the persistently high death rates to the effects of an “increasingly poisoned drug supply,” primarily with the powerful synthetic opioid fentanyl.

    Fentanyl was present in 93% of the overdose deaths where a toxicology report was available, state officials noted.

    Curbing opioid addiction has been a major focus on Beacon Hill for a number of years with hundreds of millions of dollars being devoted to expanding treatment and prevention efforts.

    The state has set some of the strictest opioid prescribing laws in the nation, including a cap on new prescriptions in a seven-day period and a requirement that doctors consult a state prescription monitoring database before prescribing an addictive opioid.

    The Opioid Recovery and Remediation Fund, created by the state Legislature in 2020, has received more than $101 million from settlements with drug makers and distributors over their alleged role in the opioid crisis, according to the Executive Office of Health and Human Services.

    More than 25,000 people have died from opioid-related overdoses in Massachusetts since 2011, according to state records.

    Nationally, fatal drug overdoses fell by roughly 3% in 2023, according data from the U.S. Centers for Disease Control and Prevention.

    But the toll from fatal overdoses in 2023 remained high, claiming 107,543 lives, the federal agency said.

    Fentanyl and other synthetic opioids were responsible for about 70% of lives lost, while methamphetamine and other synthetic stimulants are responsible for about 30% of deaths, the CDC said.

    “The shift from plant-based drugs, like heroin and cocaine, to synthetic, chemical-based drugs, like fentanyl and methamphetamine, has resulted in the most dangerous and deadly drug crisis the United States has ever faced,” Anne Milgram, head of the Drug Enforcement Administration, said in a recent statement.

    The DEA points to Mexican drug cartels, who it says are smuggling large quantities of fentanyl and other synthetic drugs manufactured in China into the country, along the southern border.

    “The suppliers, manufacturers, distributors, and money launderers all play a role in the web of deliberate and calculated treachery orchestrated by these cartels,” she said.

    [ad_2]

    By Christian M. Wade | Statehouse Reporter

    Source link

  • Report: Injured workers at risk for opioid overdoses

    Report: Injured workers at risk for opioid overdoses

    [ad_1]

    Workers who are injured on the job are at higher risk for fatal opioid-related overdoses, according to a new study, which calls for renewed efforts to reduce the stigma of drug addiction.

    The report, released Thursday by the state Department of Public Health, found that working-age Massachusetts residents who died between 2011 and 2020 were 35% more likely to have died of an opioid-related overdose if they had previously been injured at work.

    DPH researchers compiled information about individuals’ employment and work-related injury status from their workers’ compensation claims and linked it to data from their death certificates.

    Researchers reviewed the details of 4,304 working-age adults who died between 2011 and 2020 and found at least 17.2% had at least one workplace injury claim and died of an opioid-related overdose, according to the study.

    Public health officials say the study is the first linking the impact of work-related injuries to opioid-related overdose deaths.

    “Occupational injuries can take both a physical and mental toll, and those who suffer injuries at work may be discouraged from seeking help because of stigmatization and fear of losing their jobs,” Health and Human Services Secretary Kate Walsh said in a statement. “Avoiding or delaying care can lead to a preventable overdose death.”

    Walsh called for stepped-up efforts to “eliminate the stigma that accompanies substance use disorder in all sectors of society, including the workplace.”

    The release of the report comes as opioid overdose deaths remain devastatingly high in the Bay State, despite a slight decrease over the past year.

    There were 2,323 confirmed or suspected opioid-related deaths in Massachusetts from Oct. 1, 2022, to Sept. 30, 2023 — eight fewer than the same period in 2021, according to a report released in December by the health department.

    Health officials attributed the persistently high death rates to the effects of an “increasingly poisoned drug supply,” primarily with the powerful synthetic opioid fentanyl.

    Fentanyl was present in 93% of the overdose deaths where a toxicology report was available, state officials noted.

    Curbing opioid addiction has been a major focus on Beacon Hill for a number of years with hundreds of millions of dollars being devoted to expanding treatment and prevention efforts.

    The state has set some of the strictest opioid-prescribing laws in the nation, including a cap on new prescriptions in a seven-day period and a requirement that doctors consult a state prescription monitoring database before prescribing an addictive opioid.

    The Opioid Recovery and Remediation Fund, created by the state Legislature in 2020, has received more than $101 million from settlements with drug makers and distributors over their alleged role in the opioid crisis, according to the Executive Office of Health and Human Services.

    More than 25,000 people have died from opioid-related overdoses in Massachusetts since 2011, according to state records.

    Nationally, fatal drug overdoses fell by roughly 3% in 2023, according data from the U.S. Centers for Disease Control and Prevention.

    But the toll from fatal overdoses in 2023 remained high, claiming 107,543 lives, the federal agency said.

    Fentanyl and other synthetic opioids were responsible for approximately 70% of lives lost, while methamphetamine and other synthetic stimulants are responsible for approximately 30% of deaths, the CDC said.

    “The shift from plant-based drugs, like heroin and cocaine, to synthetic, chemical-based drugs, like fentanyl and methamphetamine, has resulted in the most dangerous and deadly drug crisis the United States has ever faced,” Anne Milgram, head of the Drug Enforcement Administration, said in a recent statement.

    The DEA points to Mexican drug cartels, who it says are smuggling large quantities of fentanyl and other synthetic drugs manufactured in China into the country along the southern border.

    “The suppliers, manufacturers, distributors, and money launderers all play a role in the web of deliberate and calculated treachery orchestrated by these cartels,” she said.

    Christian M. Wade covers the Massachusetts Statehouse for North of Boston Media Group’s newspapers and websites. Email him at cwade@cnhinews.com.

    [ad_2]

    By Christian M. Wade | Statehouse Reporter

    Source link

  • Safety net hospital fund shortfall widening

    Safety net hospital fund shortfall widening

    [ad_1]

    BOSTON — Lawmakers are seeking more support for the state’s safety net hospitals amid rising concerns about the fiscal health of a fund that helps cover medical costs for large numbers of uninsured and low-income patients.

    Hospitals and health insurers pay into the so-called safety net fund – a pool of money that helps fund care for hundreds of thousands of low-income residents who are uninsured or underinsured – with the state chipping in additional funding. But if the fund runs low, hospitals are on the hook for the shortfall.

    The fund is projected to have a shortfall of more than $220 million in the upcoming fiscal year, hospitals say, rising to the highest level in nearly two decades.

    Without additional funding, financially challenged hospitals will be forced to cover the deficit, leaving less money to provide medical care for low-income and uninsured patients, they say.

    An amendment to the Senate’s version of the $57.9 billion state budget filed by Sen. Barry Finegold, D-Andover, would require commercial health insurance companies to cover 50% of any revenue shortfalls in the safety net fund.

    “We need to do something to help our local hospitals,” Finegold said. “This is part of a long-term problem with funding for hospitals that serve the state’s most vulnerable residents. We need to fix it.”

    Many earmarks

    Finegold’s proposal is one of more than 1,000 amendments to the Senate’s budget, many of them local earmarks seeking to divert more state money to local governments, schools, cash-strapped community groups and nonprofits. Only a handful will likely make it into the Senate’s final spending package.

    The plan faces pushback from the Massachusetts Association of Health Plans, which represents commercial insurers who would be impacted by the proposed changes to the hospital safety net program.

    Lora Pellegrini, the group’s president and CEO, said requiring insurers to cover the fund’s shortfalls would jeopardize negotiations between the state Department of Health and Human Services and the U.S. Centers for Medicare and Medicaid Services that seek to reduce assessments paid by medical insurance carriers.

    “This really came out of nowhere, and would be counterproductive to those efforts,” she said. “We have a committee process for a reason and that’s where these kinds of special interest issues should be vetted, not in the budget.”

    But the move is backed by the Massachusetts Health and Hospital Association, which says requiring insurers to cover the shortfall would help alleviate an “unmanageable financial burden” on the health care system “by broadening funding support for the program.”

    “The Health Safety Net is a vital component of Massachusetts’ healthcare infrastructure and its ability to cover the costs of care for low-income and uninsured patients,” Daniel McHale, MHP’s vice president for Healthcare Finance & Policy, said in a statement.

    “At this increasingly fragile time for the entire health care system, it is imperative that we take the steps needed to stabilize the safety net for the people and providers who rely on it each day.”

    Local hospitals affected

    The state’s safety net hospitals and community health centers – which include Lawrence Hospital, Salem Hospital, Holy Family Hospital in Methuen and Anna Jaques Hospital in Newburyport – serve a disproportionate percentage of low-income patients.

    Many are heavily dependent on Medicaid reimbursements, which are typically less than commercial insurance payouts.

    Nearly 30% of Lawrence General’s gross revenue is for care provided to Medicaid, or MassHealth, patients. The state average is 18%.

    Many community hospitals are collecting from low-paying government insurance programs, and getting below-average reimbursements from commercial insurers, advocates say.

    Lawmakers also swept money from the hospital safety net fund to help cover the costs of new Medicare savings programs that pay some or all of eligible senior citizen’s premiums and other health care costs, including prescriptions.

    Hospitals are also seeing increased demand from uninsured patients as hundreds of thousands of Medicaid recipients see their state-sponsored health care coverage dropped following the end of federal pandemic-related programs, which is driving up costs. Claims processing problems are another factor adding to hospital costs, they say.

    Those and other factors have widened the fund’s shortfall from $68 million in fiscal 2022 to more than $210 million in the previous fiscal year, according to the hospital association. Combined, the shortfall could reach $600 million for the three fiscal years, the association said.

    Biggest expense

    The House, which approved its $58.2 billion version of the state budget two weeks ago, proposed $17.3 million in state funding for the hospital safety net fund. The Senate, which begins debate on its version of the budget next week, has proposed a similar amount.

    In the current budget, the state allocated $91.4 million for the safety net fund.

    But the House budget didn’t include an amendment requiring insurers to help hospitals pay the shortfall. That means even if the Senate approves Finegold’s amendment, it would still need to be negotiated as part of the final budget before landing on Gov. Maura Healey’s desk for consideration.

    Health care coverage, in the meantime, is one of the state’s biggest expenses. Medicaid costs have doubled in the past decade and now account for nearly 40% of state spending.

    MassHealth serves more than 2 million people – roughly one-third of the state’s population – despite federal Medicaid redeterminations that have reduced its rolls over the past year.

    [ad_2]

    By Christian M. Wade | Statehouse Reporter

    Source link

  • America Is Having a Senior Moment on Vaccines

    America Is Having a Senior Moment on Vaccines

    [ad_1]

    For years now, health experts have been warning that COVID-era politics and the spread of anti-vaxxer lies have brought us to the brink of public-health catastrophe—that a Great Collapse of Vaccination Rates is nigh. This hasn’t come to pass. In spite of deep concerns about a generation of young parents who might soon give up on immunizations altogether—not simply for COVID, but perhaps for all disease—many of the stats we have are looking good. Standard vaccination coverage among babies and toddlers, including the pandemic babies born in 2020, is “high and stable,” the CDC reports. And kindergarteners’ immunization rates, which dipped after the pandemic started, are no longer losing ground.

    Whatever gaps in early childhood vaccination were brought on by the chaos of early 2020 have since been reversed, Alison Buttenheim, a professor of nursing and health policy at the University of Pennsylvania, told me: “We’ve substantially caught up, which is incredible. It’s actually an amazing feat.”

    But even in the shadow of this triumph, a more specific crisis in vaccine acceptance has emerged. Americans aren’t now suspicious of inoculations on the whole—the nation isn’t anti-vax—but we have lost faith in yearly COVID shots. Barely any children have been getting them. Among adults, the drop in uptake has been rapid and relentless: By the spring of 2022, 56 percent of all adults had received their initial booster shot; a year later, just 28 percent were up to date; so far this COVID season, just 19 percent can say the same.

    Of course, the dangers from infection have been dropping too. Almost all of us have been exposed to COVID at this point, either through prior immunization, natural infection, or—most likely—both. That makes the disease much less deadly than it’s ever been before. (Among kids, the CDC now attributes “0.00%” of weekly deaths to COVID.) But for one age group in particular—people over 65—the crashing vaccination rates should inspire dread. More than 1,500 deaths each week are still associated with COVID, and almost all of them are senior citizens; current data hint that COVID has been killing seniors at seven times the rate of flu. Across the nation’s nursing homes and retirement communities, the Great Collapse is real.

    Like younger American adults, seniors haven’t been avoiding all recommended immunizations, just the ones for COVID. Their flu-shot rates have gone down a little in the past few years, but only by a handful of percentage points from a pandemic-driven, all-time high of 75 percent. This season, about 70 percent of people over 65 have received their flu vaccine, in line with average rates that haven’t changed that much for decades. In the meantime, seniors’ uptake of the latest COVID shots has fallen off by more than half since 2022, to just 38 percent. These diverging rates—steady for the flu, plummeting for COVID—are notably at odds with the attendant risks. Seniors seem to understand the value of inoculating themselves against the flu. So why do they forgo the same precaution against something so much worse?

    One might blame the toxic political battles around vaccines, and rampant misinformation about their ill effects. “Something terrible has happened to broaden and intensify public rejection of vaccines and other biomedical innovations in the United States,” the vaccine expert Peter Hotez wrote in his recent book The Deadly Rise of Anti-science. Certainly, toxic politics and rampant misinformation exist, but the turn against the experts that Hotez and others have decried doesn’t really fit the emergency described above. Taken as a whole, the population of Americans over 65 is hardly soured on vaccines. Nor are they afraid of COVID vaccination in particular: Though political divides persist, more than 95 percent of seniors received their initial round of shots. More than 95 percent!

    Echoing Hotez in an opinion piece for JAMA that came out last week, the FDA commissioner, Robert Califf, and a senior FDA official named Peter Marks cited the abysmal uptake of COVID shots by senior citizens as one of several signs that the country is nearing “a dangerous tipping point” on vaccination, driven by an oceanic online tide of vaccine misinformation. (Health-care providers should try to stem that tide, they wrote, with “large amounts of truthful, accessible scientific evidence.”) But the volume and intensity of anti-vaccine rhetoric seems to have diminished somewhat since 2022, Buttenheim told me: “You’d have to come up with some reason why it’s having more of an effect now than it did over the past couple of years.”

    Confusion and fatigue may well be bigger factors here than fear or false beliefs. Many Americans, young and old, have long since moved beyond the pandemic in their daily life, and may not want to think about the topic long enough to schedule another shot. The fact that people are fed up with COVID and all of the arguments it spawned is a “major drag on uptake of the vaccine,” Noel Brewer, a professor who studies health behavior at the University of North Carolina at Chapel Hill, told me. Along with many other adults, seniors have also been thrown off by changes in what the shot is called and when it’s recommended for which groups. Buttenheim doesn’t think that people are particularly afraid of this year’s dose. “This is not, like, Back off,” she said. “It’s like, Oh, there is one?

    Another theory holds that the CDC is responsible for this indifference, by pushing yearly COVID shots on people of all ages, including those for whom the net benefits of further vaccination are hard to see. In the U.K., where a much narrower group of people is eligible for updated COVID shots, uptake among seniors has been almost double what it is in the U.S., at 70 percent. That’s not because the British health-care system is better organized than ours—or not only on account of that. Even in that context, British seniors only get their flu shots at a rate that’s slightly higher than American seniors do.

    The broader rollout could contribute to the problem, Rupali Limaye, an epidemiologist who studies health communication at Johns Hopkins University, told me: “When it’s a blanket recommendation, it does dilute the message.” The CDC’s messaging on COVID shots has the benefit of being simple, but at the cost of being less persuasive for the people who are at highest risk. Then again, all Americans above the age of six months are advised to get the flu shot, and more or less the same proportions do so every year. That’s a product of our training, Brewer told me: “The U.S. has invested for decades in developing the habit of getting an annual flu shot. Older adults know that this is the thing they need to do, and they are used to it.”

    Even more important than the habit of getting flu shots is the habit of supplying them. Local clinics, businesses, and retirement communities know how to give these vaccinations (and they understand how the costs will be covered); they’ve been doing this for years. Buttenheim told me that her university sets up a flu-shot clinic every fall, where she can usually get immunized in less than 90 seconds. But the equivalent for COVID shots is yet to become routine. Where the vaccines are available, appointments have been canceled over missing doses or mix-ups with insurance. Government efforts to improve access were delayed.

    With the end of the pandemic emergency, obtaining a COVID shot has simply gotten harder, no matter your intentions or beliefs. “The very well-structured and scaffolded process for getting those vaccines before has just evaporated,” Buttenheim said. For the uptake rates to turn around, a new, post-emergency system for delivery might have to be established, with less confusion over cost and coverage. Even that development alone would do a lot to end the geriatric vaccine crash. If COVID shots could be made as standardized and reflexive as the ones for flu, seasonal vaccination rates might start rising once again, at least until about two-thirds of people over 65 are getting shots. That’s the rate we see for flu shots, and probably an upper limit, Brewer said: “We won’t do better than that.”

    [ad_2]

    Daniel Engber

    Source link

  • Trump Is Coming for Obamacare Again

    Trump Is Coming for Obamacare Again

    [ad_1]

    Donald Trump’s renewed pledge on social media and in campaign rallies to repeal and replace the Affordable Care Act has put him on a collision course with a widening circle of Republican constituencies directly benefiting from the law.

    In 2017, when Trump and congressional Republicans tried and failed to repeal the ACA, also known as Obamacare, they faced the core contradiction that many of the law’s principal beneficiaries were people and institutions that favored the GOP. That list included lower-middle-income workers without college degrees, older adults in the final years before retirement, and rural communities.

    In the years since then, the number of people in each of those groups relying on the ACA has grown. More than 40 million Americans now receive health coverage through the law, about 50 percent more than the roughly 27 million the ACA covered during the repeal fight in 2017. In the intervening years, nine more states, most of them reliably Republican, have accepted the law’s federal funding to expand access to Medicaid for low-income working adults.

    “Republicans came very close to repealing and replacing the ACA in 2017, but that may have been their best window before the law had fully taken hold and so many people have benefited from it,” Larry Levitt, the executive vice president for health policy at KFF, a nonpartisan think tank that studies health-care issues, told me. “I think it gets harder and harder to repeal as more people benefit.”

    Trump’s repeated declarations over the past several weeks that he intends to finally repeal the ACA if reelected surprised many Republicans. Few GOP leaders have talked about uprooting the law since the party’s last effort failed, during Trump’s first year as president. At that point, Republicans controlled both chambers of Congress. But whereas the House, with Trump’s enthusiastic support, narrowly voted to rescind the law, the Senate narrowly rejected repeal. Three GOP senators blocked the repeal effort by voting no—including the late Senator John McCain, who dramatically doomed the proposal by signaling thumbs-down on the Senate floor. (Trump mocked McCain while calling the ACA “a catastrophe” as he campaigned in Iowa last weekend.)

    Republicans lost any further opportunity to repeal the law in the 2018 election when Democrats regained control of the House of Representatives. With the legislative route blocked, Trump instead pursued an array of regulatory and legal efforts to weaken the ACA during his final years in office. But since the 2017 vote, the GOP has never again held the unified control of the White House, the House, and the Senate required to launch a serious legislative repeal effort.

    If Republicans did win unified control of Congress and the White House next November, most health-care experts I spoke with agreed that Trump would follow through on his promises to again target the ACA. Leslie Dach, the founder of Protect Our Care, a liberal group that supports the law, says that he takes Trump’s pledge to pursue repeal seriously, “because he is still trying to overturn the legacy of John McCain, and it’s one of the few things he lost. He doesn’t like to be a loser.”

    Trump hasn’t specified his plan to replace the ACA. But whatever alternative Trump develops will inevitably face one of the main problems that confounded Republicans’ last attempt at repeal: Every plan they put forward raised costs and diminished access to care for core groups in their electoral coalition.

    That was apparent in the contrast between how the ACA and the GOP alternatives treated the individual insurance market. The ACA created exchanges where the uninsured could buy coverage, provided them with subsidies to help them afford it, and changed the rules about what kind of policies insurers could sell them. Key among those changes were provisions that barred insurers from denying coverage to people with preexisting health conditions, required them to offer a broad package of essential health benefits in all policies, and prevented them from charging older consumers more than three times the premiums of younger people.

    The common effect of all these and many other requirements was to require greater risk sharing in the insurance markets. The ACA made coverage in the individual insurance market more available and affordable for older and sicker consumers partly by requiring younger and healthier consumers to purchase more expensive and comprehensive plans than they might have bought before the law went into effect. That shift generated complaints from relatively younger and healthier consumers in the ACA’s early years as their premiums increased.

    Every alternative that Republicans proposed during the Trump years sought to lower premiums by unraveling the ACA provisions that required more sharing of risks and costs. For instance, the House GOP plan allowed insurers to charge seniors five times as much as young people, reduced the number of guaranteed essential benefits, and allowed states to exempt insurers from the requirement to cover all applicants with preexisting health conditions.

    One problem the GOP faced was that although this approach might have lowered premiums for the young and healthy (albeit while leaving them with less comprehensive coverage), it would have significantly raised costs and reduced access for the old or sick. “A lot of ‘repeal and replace’ was putting more cost back on people with health-care problems,” Linda Blumberg, an institute fellow at the Urban Institute’s Health Policy Center, told me. The Rand Corporation calculated that for individuals with modest incomes, the House GOP plan would have cut premiums for the majority of those under age 45 while raising them for virtually everyone older than 45. The Congressional Budget Office, in its assessment of the House-passed GOP bill, projected that it would nearly double the number of people without health insurance by 2026, and that the greatest coverage losses would happen “among older people with lower income.”

    As I wrote in 2017, the paradox was that the Republican plans would have hurt older working-age adults—a preponderantly GOP-leaning constituency—while lowering costs for younger generations that mostly vote Democratic. I called this inversion the “Trumpcare conundrum.”

    The congressional Republican alternatives to the ACA under Trump also uniformly made deep cuts to Medicaid, the joint state-federal health-care program for low-income people. But GOP constituencies were big winners as well in the ACA provisions that expanded eligibility for Medicaid.

    Until the ACA, Medicaid was generally available only to adults earning less than the federal poverty level. But the law provided states with generous federal financing to expand coverage to low-income individuals earning up to 138 percent of the poverty level. Particularly in interior states, research showed that many of those low-income workers covered under the Medicaid expansion were white people without a college degree, the cornerstone of the modern Republican electoral coalition.

    Another big beneficiary from the Medicaid expansion was rural communities, which have become more reliably Republican in the Trump years. Expanding access to Medicaid was especially important to rural places because studies have consistently found that more people in those areas than in metropolitan centers suffer from chronic health problems, while fewer obtain health insurance from their employer, and more lack insurance altogether.

    The increased number of people covered under Medicaid gave rural hospitals a lifeline by reducing the amount of uncompensated care they needed to provide for patients lacking insurance. “When you go out to the rural areas, frankly most hospital executives, like other business people, they tend to be pretty conservative,” Timothy McBride, a co-director of the Center for Advancing Health Services, Policy & Economics Research at Washington University in St. Louis, told me. “And they don’t like government intervention. But I would go to see these people and they would say, ‘I’m for Medicaid expansion,’ because they had to deal with the uninsured.”

    The Medicaid expansion also quickly became a crucial source of financing for addiction treatment in states ravaged through the 2010s by the opioid epidemic. Before the ACA, addiction treatment programs relied on “a little bit of block grant money here, a local voucher there, kind of out-of-pocket payments, and a little bit of spit and glue,” Brendan Saloner, a professor at the Johns Hopkins Bloomberg School of Public Health who studies addiction, told me. “Then Medicaid came along, and it provided a much more reliable and stable source of payment.”

    Since the 2017 legislative battle, the ACA’s impact on all these fronts has only deepened. Biden and congressional Democrats both increased the federal subsidies to buy insurance on the Obamacare exchanges and expanded eligibility to families further into the middle class. Largely as a result, the number of people obtaining insurance through the exchanges soared from about 10 million then to more than 15 million as of this past December.

    Similarly, a majority of the 31 states that had expanded Medicaid by 2017 were solidly Democratic-leaning. But the nine additional states that have broadened eligibility since then include seven that voted for Trump in 2016 and 2020.

    That has not only increased the total number of low-income workers covered through the Medicaid expansion (from about 16 million then to well over 24 million now), but also broadened the red-state constituency for the ACA. McBride estimates that the federal government has annually pumped $2 billion into the health-care system in Missouri alone since voters there approved a Medicaid expansion in 2020. The federal Department of Health and Human Services recently calculated that the likelihood of rural hospitals closing was more than twice as high in the states that have refused to expand Medicaid than in those that have. Simultaneously, the amount of funding that Medicaid provides for the treatment of substance abuse has at least doubled since 2014, allowing it to serve nearly 5 million people, according to calculations by Tami Mark, a distinguished fellow in behavioral health at RTI International, a nonprofit independent research institute.

    Even more fundamentally, Blumberg argues, the pandemic showed the ACA’s value as a safety net. Through either the exchanges or Medicaid, the law provided coverage to millions who lost their job, and insurance, during the crisis. “This law was critical in protecting us from unforeseen circumstances even beyond the value that people had seen in 2017,” she told me. “If we had not had that in place, we would have seen massive amounts of uninsurance and people who could not have accessed vaccines and could not have accessed medical care when they became sick.”

    For all of these reasons and more, Douglas Holtz-Eakin, the president of the American Action Forum, a conservative think tank, told me that he believes it’s a mistake for Trump and the GOP to seek repeal once again. Holtz-Eakin, a former director of the Congressional Budget Office, remains critical of the ACA, which he says has not done enough to improve the quality of coverage or control costs.

    But, he points out, during the Trump years, Republicans succeeded in repealing some of the law’s elements that they disliked most, including the tax penalty on uninsured people who did not buy coverage. “I don’t think we should be happy with the current system,” Holtz-Eakin told me. “But it’s not fruitful to try to roll the clock back to 2010.”

    Beyond the policy challenges of excising the ACA from the health-care system, the political landscape also appears less hospitable to a renewed repeal drive. In 2017, KFF polling found that the share of Americans who viewed the law favorably only slightly exceeded the share dubious of it; in the group’s most recent survey measuring attitudes toward the law, more than three-fifths of Americans expressed favorable views, while only slightly more than one-third viewed it negatively. Support for individual provisions in the law, such as the ban on denying coverage because of preexisting conditions or the requirement that insurers allow kids to stay on their parents’ plans through age 26, runs even higher in polls.

    Yet even with all these obstacles, Trump’s promise to seek repeal again virtually ensures another round of the ACA war next year if Republicans win unified control of the federal government. By historical standards, that’s a remarkable, even unprecedented, prospect. Though Barry Goldwater, the 1964 GOP nominee, had opposed the creation of Medicare, for instance, no Republican presidential nominee ever proposed to repeal it after Lyndon B. Johnson signed it into law in 1965.

    If Trump wins the nomination, by contrast, it would mark the fourth consecutive time the GOP nominee has run on ending the ACA. (Among Trump’s main competitors, Florida Governor Ron DeSantis has also promised to produce an alternative to the ACA, and Nikki Haley, who has spoken less definitively on the topic, might feel irresistible pressure to embrace repeal too.) Congressional Republicans may have been surprised that Trump committed them to charging up that hill again, but that doesn’t mean they would refuse his command to do so. “He wants to reverse a loss and take it off the books,” Dach told me. “And we’ve learned that that party follows him. It’s not like they are going to stand up against him, especially in the House. They will destroy the law if they can.”

    [ad_2]

    Ronald Brownstein

    Source link

  • Life Is Worse for Older People Now

    Life Is Worse for Older People Now

    [ad_1]

    Last December, during a Christmas Eve celebration with my in-laws in California, I observed what I now realize was the future of COVID for older people. As everyone crowded around the bagna cauda, a hot dipping sauce shared like fondue, it was clear that we, as a family, had implicitly agreed that the pandemic was over. Our nonagenarian relatives were not taking any precautions, nor was anyone else taking precautions to protect them. Endive spear in hand, I squeezed myself in between my 94-year-old grandfather-in-law and his spry 99-year-old sister and dug into the dip.

    We all knew that older people bore the brunt of COVID, but the concerns seemed like a relic from earlier in the pandemic. The brutal biology of this disease meant that they disproportionately have fallen sick, been hospitalized, and died. Americans over 65 make up 17 percent of the U.S. population, but they have accounted for three-quarters of all COVID deaths. As the death count among older people began to rise in 2020, “a lot of my patients were really concerned that they were being exposed without anyone really caring about them,” Sharon Brangman, a geriatrician at SUNY Upstate University Hospital, told me.

    But even now, three years into the pandemic, older people are still in a precarious position. While many Americans can tune out COVID and easily fend off an infection when it strikes, older adults continue to face real threats from the illness in the minutiae of their daily life: grocery trips, family gatherings, birthday parties, coffee dates. That is true even with the protective power of several shots and the broader retreat of the virus. “There is substantial risk, even if you’ve gotten all the vaccines,” Bernard Black, a law professor at Northwestern University who studies health policy, told me. More than 300 people still die from COVID each day, and the overwhelming majority of them are older. People ages 65 and up are currently hospitalized at nearly 11 times the rate of adults under 50.

    Compounding this sickness are all the ways that, COVID aside, this pandemic has changed life for older adults. Enduring severe isolation and ongoing caregiver shortages, they have been disproportionately harmed by the past few years. Not all of them have experienced the pandemic in the same way. Americans of retirement age, 65 and older, are a huge population encompassing a range of incomes, health statuses, living situations, and racial backgrounds. Nevertheless, by virtue of their age alone, they live with a new reality: one in which life has become more dangerous—and in many ways worse—than it was before COVID.


    The pandemic was destined to come after older Americans. Their immune systems tend to be weaker, making it harder for them to fight off an infection, and they are more likely to have comorbidities, which further increases their risk of severe illness. The precarity that many of them already faced going into 2020—poverty, social isolation and loneliness, inadequate personal care—left them poorly equipped for the arrival of the novel coronavirus. More than 1 million people lived in nursing homes, many of which were densely packed and short on staff when COVID tore through them.

    A major reason older people are still at risk is that vaccines can’t entirely compensate for their immune systems. A study recently published in the journal Vaccines showed that for vaccinated adults ages 60 and over, the risk of dying from COVID versus other natural causes jumped from 11 percent to 34 percent within a year of completing their primary shot series. A booster dose brings the risk back down, but other research shows that it wears off too. A booster is a basic precaution, but “not one that everyone is taking,” Black, a co-author of the study, told me. Booster uptake among older Americans for the reengineered “bivalent” shots is the highest of all age groups, but still, nearly 60 percent have not gotten one.

    For every COVID death, many more older people develop serious illness. Risk increases with age, and people older than 70 “have a substantially higher rate of hospitalizations” than those ages 60 to 69, Caitlin Rivers, an epidemiologist at Johns Hopkins University, told me. Unlike younger people, most of whom fully recover from a bout with COVID, a return to baseline health is less guaranteed for older adults. In one study, 32 percent of adults over 65 were diagnosed with symptoms that lasted well beyond their COVID infection. Persistent coughs, aches, and joint pain can linger long after serious illness, together with indirect impacts such as loss of muscle strength and flexibility, which can affect older people’s ability to be independent, Rivers said. Older COVID survivors may also have a higher risk of cognitive decline. In some cases, these ailments could be part of long COVID, which may be more prevalent in older people.

    Certainly, some older adults are able to make a full recovery. Brangman said she has “old and frail” geriatric patients who bounced back after flu-like symptoms, and younger ones who still experience weakness and fatigue. Still, these are not promising odds. The antiviral Paxlovid was supposed to help blunt the wave of old people falling sick and ending up in the hospital—and it can reduce severe disease by 50 to 90 percent. But unfortunately, it is not widely used; as of July, just a third of Americans 80 or older took Paxlovid.

    The reality is that as long as the virus continues to be prevalent, older Americans will face these potential outcomes every time they leave their home. That doesn’t mean they will barricade themselves indoors, or that they even should. Still, “every decision that we make now is weighing that balance between risk and socialization,” Brangman said.


    Long before the pandemic, the threat of illness was already very real for older people.  Where America has landed is hardly a new way of life but rather one that is simply more onerous. “One way to think about it is that this is a new risk that’s out there” alongside other natural causes of death, such as diabetes and heart failure, Black said. But it’s a risk older Americans can’t ignore, especially as the country has dropped all COVID precautions. Since Christmas Eve, I have felt uneasy about how readily I normalized putting so little effort into protecting my nonagenarian loved ones, despite knowing what might happen if they got sick. For older people, who must contend with the peril of attending similar gatherings, “there’s sort of no good choice,” Black said. “The world has changed.”

    But this new post-pandemic reality also includes insidious effects on older people that aren’t directly related to COVID itself. Those who put off nonemergency visits to the doctor earlier in the pandemic, for example, risked worsening their existing health conditions. The first year of the pandemic plunged nearly everyone into isolation, but being alone created problems for older adults that still persist. Before the pandemic, the association between loneliness and higher mortality rates, increased cardiovascular risks, and dementia among older adults was already well established. Increased isolation during COVID amplified this association.

    The consequences of isolation were especially profound for older adults with physical limitations, Naoko Muramatsu, a community-health professor at the University of Illinois at Chicago, told me. When caregivers or family members were unable to visit, people who required assistance for even the smallest tasks, such as fetching the mail and getting dressed, had no options. “If you don’t walk around and if you don’t do anything, we can expect that cognitive function will decline,” Muramatsu said; she has observed this firsthand in her research. One Chinese American woman, interviewed in a survey of older adults living alone with cognitive impairment during the pandemic, described the debilitating effect of sitting at home all day.“I am so useless now,” she told the interviewer. “I am confused so often. I forget things.”

    Even older adults who have weathered the direct and indirect effects of the pandemic still face other challenges that COVID has exacerbated. Many have long relied on personal caregivers or the staff at nursing facilities. These workers, already scarce before the pandemic, are even more so now because many quit or were affected by COVID themselves. “Long-term care has been in a crisis situation for a long time, but it’s even worse now,” Muramatsu said, noting that many home care workers are older adults themselves. Nursing homes nationwide now have nearly 200,000 fewer employees compared with March 2020, which is especially concerning as the proportion of Americans over age 65 explodes.

    Older people won’t have one single approach to contending with this sad reality. “Everybody is trying to figure out what is the best way to function, to try to have some level of everyday life and activity, but also keep your risk of getting sick as low as possible,” Brangman said. Some of her patients are still opting to be cautious, while others consider this moment their “only chance to see grandchildren or concerts or go to family gatherings.” Either way, older Americans will have to wrestle with these decisions without so many of their peers who have died from COVID.

    Again, many of these people did not have it great before the pandemic, even if the rest of the country wasn’t paying attention. “We often don’t provide the basic social support that older people need,” Kenneth Covinsky, a clinician-researcher at the UCSF Division of Geriatrics, said. Rather, ageism, the willful ignorance or indifference to the needs of older people, is baked into American life. It is perhaps the main reason older adults were so badly affected by the pandemic in the first place, as illustrated by the delayed introduction of safety precautions in nursing homes and the blithe acceptance of COVID deaths among older adults. If Americans couldn’t bring themselves to care at any point over the past three years, will they ever?

    [ad_2]

    Yasmin Tayag

    Source link